Orthocell Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Orthocell Ltd with three other
pharmaceutical manufacturers in Australasia:
Anatara Lifesciences Ltd
(2019
sales of 842,547.00 Australian Dollars [US$563,200.54 ]
),
MGC Pharmaceuticals Ltd
(858,087.00 Australian Dollars [US$573,588.26 ]
), and
Auscann Group Holdings Ltd
(861,770.00 Australian Dollars [US$576,050.16 ]
).
Sales Analysis.
Orthocell Ltd reported sales of A$956,472.00 (US$639.35 thousand)
for the
fiscal
year ending
June of 2019.
This
represents
an
increase of 50.0%
versus 2018, when the company's sales were A$637,648.00 .
Despite this increase, sales are still
below the level achieved in 2017, when Orthocell Ltd
reported sales of A$1.08 million.